Loading insider details...
Latest Form 4 (Jul 2, 2026): Exercise/Conversion of 10,000 HALO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Exercise/Conversion | 10,000 | n/a |
| Apr 2, 2026 | HALOZYME THERAPEUTICS, INC. (HALO) | Grant/Award | 10,000 | n/a |
| Dec 19, 2025 | Savara Inc (SVRA) | Sale | 20,000 | $121.2K |
| Dec 11, 2025 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Apr 1, 2025 | Savara Inc (SVRA) | Purchase | 150,000 | $416.3K |
| Dec 16, 2024 | Savara Inc (SVRA) | Grant/Award | 40,000 | n/a |
| Nov 18, 2024 | Savara Inc (SVRA) | Purchase | 100,000 | $287.6K |
| Dec 15, 2023 | Savara Inc (SVRA) | Grant/Award | 22,500 | n/a |
| May 26, 2023 | Savara Inc (SVRA) | Purchase | 50,000 | $127.8K |
| Jan 3, 2023 | Savara Inc (SVRA) | Purchase | 7,000 | $10.8K |